We are delighted to announce that Micromass, an Ashfield company, part of UDG Healthcare plc, has been named a finalist for the ‘Use of Relationship Marketing’ in the MM&M awards.
Micromass have excelled in the ‘Use of Relationship Marketing’ category with the ZEJULA My Way Patient Support RM programme. After rigorous assessment Micromass’ ZEJULA programme was recognised as one of 5 finalists!
This is fantastic work, recognised by MM&M, who award creativity in healthcare marketing & communications and something which Ashfield value highly.
The ZEJULA My Way Patient Support RM programme aims to enable women taking ZEJULA to stay on treatment as long as possible. This will be accomplished by helping each patient:
- Build skills to manage a daily routine that includes ZEJULA and any associated side effects
- Identify and address emotional needs, so she can stay positive, motivated, and move forward
- Address unmet psychosocial support-related needs (finding support groups, recruiting a care partner, and improving communication with her care team)
- Access support-related information, tools, and resources when and how suits her.
The finalists will be announced in the August 2018 issue of MM&M. Finalists will be acknowledged and winners will be announced during the dinner gala and award presentation on Thursday, October 11, 2018 in New York.